Importance of fatty acid compositions in patients with peripheral arterial disease. - Test2 - elhamkhani - TriplyDB

Importance of fatty acid compositions in patients with peripheral arterial disease.

Importance of fatty acid compositions in patients with peripheral arterial disease.

http://www.wikidata.org/entity/Q34142519

about

Nutraceutical therapies for atherosclerosis.Unlocking nature's treasure-chest: screening for oleaginous algae.Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)

P2860

Q36068816-BCFA7125-41E9-495B-B0DA-E2D8636024AC Q37736215-FDD703CB-CF2B-4211-A0BA-B5449577140A Q57074152-8D889264-46AC-49C4-BCEF-6B01009A8A8F

P2860

Importance of fatty acid compositions in patients with peripheral arterial disease.

http://www.wikidata.org/entity/Q34142519

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Importance of fatty acid compositions in patients with peripheral arterial disease.

@ast

Importance of fatty acid compositions in patients with peripheral arterial disease.

@en

Importance of fatty acid compositions in patients with peripheral arterial disease.

@nl

type

label

Importance of fatty acid compositions in patients with peripheral arterial disease.

@ast

Importance of fatty acid compositions in patients with peripheral arterial disease.

@en

Importance of fatty acid compositions in patients with peripheral arterial disease.

@nl

prefLabel

Importance of fatty acid compositions in patients with peripheral arterial disease.

@ast

Importance of fatty acid compositions in patients with peripheral arterial disease.

@en

Importance of fatty acid compositions in patients with peripheral arterial disease.

@nl

P1433

Q34142519-6A9584D4-500D-41C2-877D-A0C10CBA9FCA

P1476

Q34142519-637F3657-AA30-44F6-A5EA-56F663F94DDB

P2093

Q34142519-0A474184-EA19-4B3C-8FDC-24332BE28317

Q34142519-10C4E620-2AA6-4103-8382-D0520D87E673

Q34142519-579B8EA6-679E-434C-83A5-2FAABD4EA45B

Q34142519-5A32243A-AD4D-48AD-8BBE-9C9F19764A0C

Q34142519-620A41A9-F894-4228-8082-F97DFC7015FA

Q34142519-9B74471F-CDEA-4666-AB98-14BB6972E363

Q34142519-AA0FC75C-B3EE-443B-8CD7-3EEE8CC613FA

Q34142519-B3CEB50E-D520-4B87-8E24-CE2BD33BBE93

Q34142519-C3560634-681F-4228-BB28-D7F0B3A6AD62

Q34142519-DA1C5E34-D501-4B70-A145-244BB850DB23

P2860

Q34142519-03EF0A1D-4BE1-46A9-A35E-FEEED475139F

Q34142519-06E9D584-1F79-4339-850F-1AC1C4C821E1

Q34142519-09702A30-C692-48FF-8D2B-D958E032F1DD

Q34142519-10379753-FA38-42ED-9F15-A9A5AEE9B290

Q34142519-10AABB69-CCE6-4014-85FB-CC716BF19D2D

Q34142519-10B56DEB-143E-4644-9832-E514603F8B1F

Q34142519-14C798B1-FC47-4050-A40F-FF97C5BC4CB4

Q34142519-1C6E3D49-684C-4145-8619-AF39D9BD6765

Q34142519-1D5560DF-5C02-426F-83BF-AA48B5EBA464

Q34142519-2A76B478-508E-4FC6-9638-7CB51E3D4FA7

P304

Q34142519-92B4F85A-F6DC-4377-94BB-93D1F8B7B2CE

P31

Q34142519-CC0CAC8B-3416-47CE-B91D-7B30D666CDB7

P356

Q34142519-F670741D-9B06-48C9-B635-EAE799C55BF9

P407

Q34142519-45E3A9E9-196D-4FE6-A817-F46B4B7A8F60

P433

Q34142519-E0B55BCC-AC1C-4384-BE8D-A740F5A2F6EE

P478

Q34142519-23B2C0E4-8189-4DDB-BFE0-5B766409AEA7

P577

Q34142519-79E427B7-2497-4925-86D8-DA7BA0B0A861

P5875

Q34142519-4AC2D981-120B-4E22-AF57-08297A95E871

P698

Q34142519-9917ED65-B9C5-4D4B-BE0E-FC590944418D

P921

Q34142519-FEFD8FB8-784B-44BE-98EE-313C70CF54CC

P932

Q34142519-7DF72E3B-A80B-49BE-B186-B8CD728CD883

P356

JOURNAL.PONE.0107003

P1433

P1476

Importance of fatty acid compositions in patients with peripheral arterial disease.

@en

P2093

Atsushi Izawa

http://www.w3.org/2001/XMLSchema#string

Ayako Okada

http://www.w3.org/2001/XMLSchema#string

Hirohiko Motoki

http://www.w3.org/2001/XMLSchema#string

Jun Koyama

http://www.w3.org/2001/XMLSchema#string

Milan Gautam

http://www.w3.org/2001/XMLSchema#string

Takahiro Takeuchi

http://www.w3.org/2001/XMLSchema#string

Takeshi Tomita

http://www.w3.org/2001/XMLSchema#string

Uichi Ikeda

http://www.w3.org/2001/XMLSchema#string

Yuji Shiba

http://www.w3.org/2001/XMLSchema#string

Yusuke Miyashita

http://www.w3.org/2001/XMLSchema#string

P2860

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

Prediction of first coronary events with the Framingham score: a systematic review.

Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality.

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

n-3 fatty acids in patients with multiple cardiovascular risk factors.

Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events.

Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.

P304

e107003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0107003

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265391177

http://www.w3.org/2001/XMLSchema#string

P698

25191963

http://www.w3.org/2001/XMLSchema#string

P921

P932

4156400

http://www.w3.org/2001/XMLSchema#string